Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
5
×
deals
5
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
5
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
5
×
wisconsin blog main
wisconsin top stories
5
×
cancer immunotherapy
eli lilly
fda
pfizer
takeda pharmaceutical
clinical trials
roche
aduro biotech
agenus
What
bio
5
×
roundup
companies
drug
drugs
fda
growing
pharmaceutical
typically
ahead
alliance
alzheimer’s
approved
asco
bails
brand
branded
bridgebio
bristol
buy
calls
capital
car
changing
choices
color
commissioner
consumers
costly
counterweight
crispr
days
develop
different
digital
disease
elevatebio
emerges
epidemic
fail
Language
unset
Current search:
investing
×
bio
×
cancer
×
" texas top stories "
×
deals
×
" wisconsin top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More